AGAPE ATP CORPORATION Increase (Decrease) in Accounts Payable, Related Parties
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Accounts Payable, Related Parties of -$947 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2026-08-14
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for the quarter ending 2026-03-31 was -$947.00, a 142.87% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for the quarter ending 2025-12-31 was $11.47K, a 116.03% increase year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for the quarter ending 2025-09-30 was $931.00.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for the quarter ending 2025-06-30 was -$597.00, a 105.42% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for fiscal 2025 was $14.01K.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for fiscal 2024 was -$5.11K, a 149.36% decline from fiscal 2023.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for fiscal 2023 was $10.35K, a 59.58% decline from fiscal 2022.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable, related parties for fiscal 2022 was $25.60K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month as first filed | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$947.00 10-Q · filed 2026-05-15 | $10.52K derived: sum of 2 quarters · filed 2026-05-15 | $11.45K derived: sum of 3 quarters · filed 2026-05-15 | $10.85K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $11.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $12.40K derived: sum of 2 quarters · filed 2026-04-13 | $11.80K derived: sum of 3 quarters · filed 2026-08-14 | $14.01K 10-K · filed 2026-04-13 | |
| 2025-09-30 | $931.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $334.00 derived: sum of 2 quarters · filed 2026-08-14 | $2.54K 10-Q · filed 2025-11-13 | $7.85K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$597.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.61K 10-Q · filed 2026-08-14 | -$885.00 10-Q · filed 2025-08-13 | $6.92K derived: sum of 3 quarters · filed 2026-08-14 | $5.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.21K 10-Q · filed 2026-05-15 | $7.52K derived: sum of 2 quarters · filed 2026-05-15 | $5.79K derived: sum of 3 quarters · filed 2026-05-15 | $16.80K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $5.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $3.58K derived: sum of 2 quarters · filed 2026-04-13 | $14.59K derived: sum of 3 quarters · filed 2026-04-13 | -$5.11K 10-K · filed 2026-04-13 | |
| 2024-09-30 | -$1.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.29K derived: sum of 2 quarters · filed 2025-11-13 | -$10.41K 10-Q · filed 2025-11-13 | -$3.86K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $11.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$8.69K 10-Q · filed 2025-08-13 | -$2.14K derived: sum of 3 quarters · filed 2025-08-13 | $6.41K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$19.70K 10-Q · filed 2025-05-15 | -$13.14K derived: sum of 2 quarters · filed 2025-05-15 | -$4.59K derived: sum of 3 quarters · filed 2025-05-15 | -$4.30K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $6.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $15.11K derived: sum of 2 quarters · filed 2025-03-31 | $15.40K derived: sum of 3 quarters · filed 2025-03-31 | $10.35K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $8.85K derived: sum of 2 quarters · filed 2024-11-14 | $3.79K 10-Q · filed 2024-11-14 | $9.03K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $296.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.76K 10-Q · filed 2024-08-14 | $482.00 derived: sum of 3 quarters · filed 2024-08-14 | $6.43K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$5.05K 10-Q · filed 2024-05-14 | $186.00 derived: sum of 2 quarters · filed 2024-05-14 | $6.14K derived: sum of 3 quarters · filed 2024-05-14 | $12.26K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $5.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $11.19K derived: sum of 2 quarters · filed 2024-04-01 | $17.32K derived: sum of 3 quarters · filed 2024-04-01 | $25.60K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $12.08K derived: sum of 2 quarters · filed 2023-11-14 | $20.36K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $6.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $14.41K 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $8.28K 10-Q · filed 2023-05-15 | ||||
| 2019-12-31 | -$35.09K 10-K · filed 2021-03-31 | $59.00 10-K · filed 2021-03-31 | |||
| 2019-06-30 | $35.15K 10-Q · filed 2020-08-13 | $35.15K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |